Drugs / DS-7309
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01956305 | Sep 2013 → Jun 2014 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 1 | NCT01862939 | Apr → Sep 2011 | type 2 diabetes mellitus | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-7309 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01862939 ↗ |
| Route | Oral | “1, 2.5, 5, and 15mg DS-7309 powder in bottle for oral solution.” NCT01862939 ↗ |